Rating Change
William Blair analysts initiated coverage on Vor Biopharma Inc. (NASDAQ:VOR) with a rating of Outperform on October 21, 2026.
new coverageNASDAQ:VOR
William Blair Initiates Coverage on Vor Biopharma Inc. (VOR) with Outperform
William Blair analysts initiated coverage on Vor Biopharma Inc. (NASDAQ:VOR) with a rating of Outperform on October 21, 2026.
At publication ·
What changed
Vor Biopharma Inc. (NASDAQ:VOR) · new coverage
- Firm
- William Blair
- Rating
- Outperform
- Price at event
- $18.94
- Market capitalization
- $83.3M
At a glance
Key takeaways
- William Blair initiated Outperform coverage on Vor Biopharma (VOR) on October 21, 2026, with the stock trading at $18.94 and a market cap of $83.3 million.
- VOR stock has declined 30% over the past 52 weeks, reflecting significant recent underperformance.
- Among the 10 most recent analyst ratings, 7 are Buy and 3 are Hold with no Sell ratings, indicating mostly positive sentiment.
- Analyst ratings and price targets are one input among many for investment decisions and have mixed predictive power on their own.
Market Context
Vor Biopharma Inc. operates in the Healthcare sector. The stock currently trades at $18.94 with a market capitalization of $83.3M. The stock has declined 30.0% over the past 52 weeks.
Analyst coverage from William Blair provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Vor Biopharma Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Vor Biopharma Inc.
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 21, 2026 | William Blair | Outperform | N/A |
| Aug 12, 2026 | Wedbush | Neutral | N/A |
| May 18, 2026 | HC Wainwright & Co. | Buy | N/A |
| May 14, 2026 | Wedbush | Neutral | N/A |
| Apr 15, 2026 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View VOR Stock Page
Frequently Asked Questions
What does the Outperform rating mean for VOR?
A rating of Outperform from William Blair reflects the analyst's outlook on Vor Biopharma Inc. (NASDAQ:VOR). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the VOR forecast page.
Loading related coverage…